LARRY WILLIAMS: Open Payments
NPI 1851830558 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 23 payments from 12 companies in 2025. Trend: 2023 $1,029 · 2024 $1,007 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $214 |
| Sumitomo Pharma America, Inc. | 5 | $103 |
| ConvaTec Inc. | 1 | $82 |
| Procept Biorobotics Corporation | 1 | $73 |
| IMMUNITYBIO, INC. | 2 | $68 |
| ABBVIE INC. | 2 | $39 |
| PFIZER INC. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| UROGEN PHARMA, INC. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: ERLEADA, GEMTESA, RYBREVANT, GENTLECATH GLIDE, AQUABEAM ROBOTIC SYSTEM, ANKTIVA, BOTOX, XTANDI.
Industry payments across FL — which companies pay providers there.
